Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-31 11:42 am Sale | 2025-09-30 | 13G | Xencor, Inc. XNCR | The Vanguard Group | 7,103,758 9.950% | -1,520,616 (-17.63%) | Filing History |
| 2025-10-17 4:56 pm Purchase | 2025-10-09 | 13G | Xencor, Inc. XNCR | BIOTECHNOLOGY VALUE FUND L P | 4,619,341 6.500% | 4,619,341 (New Position) | Filing History |
| 2025-08-14 1:29 pm Purchase | 2025-06-30 | 13G | Xencor, Inc. XNCR | PRIMECAP MANAGEMENT CO/CA/ | 10,527,322 14.790% | 1,390,127 (+15.21%) | Filing History |
| 2025-07-29 2:49 pm Purchase | 2025-06-30 | 13G | Xencor, Inc. XNCR | The Vanguard Group | 8,624,374 12.110% | 1,857,125 (+27.44%) | Filing History |
| 2025-05-13 12:33 pm Purchase | 2025-03-31 | 13G | Xencor, Inc. XNCR | STATE STREET CORP STT | 3,683,715 5.200% | 564,425 (+18.09%) | Filing History |
| 2025-04-29 3:16 pm Sale | 2025-03-31 | 13G | Xencor, Inc. XNCR | BlackRock Inc. BLK | 11,130,112 15.800% | -1,071,505 (-8.78%) | Filing History |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Xencor, Inc. XNCR | BlackRock Inc. BLK | 12,201,617 17.400% | 1,175,287 (+10.66%) | Filing History |
| 2024-11-14 6:16 pm Purchase | 2024-09-30 | 13G | Xencor, Inc. XNCR | EcoR1 Capital, LLC | 6,719,304 9.400% | 1,436,788 (+27.20%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Xencor, Inc. XNCR | PRICE T ROWE ASSOCIATES INC | 3,929,062 5.600% | 439,160 (+12.58%) | Filing History |
| 2024-11-12 4:01 pm Purchase | 2024-09-30 | 13G | Xencor, Inc. XNCR | PRIMECAP MANAGEMENT CO/CA/ | 9,137,195 13.080% | 235,588 (+2.65%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Xencor, Inc. XNCR | BlackRock Inc. BLK | 11,026,330 15.800% | 0 (Unchanged) | Filing History |
| 2024-10-21 4:18 pm Purchase | 2024-09-16 | 13G | Zenas BioPharma, Inc. ZBIO | Xencor Inc XNCR | 3,098,380 7.400% | 3,098,380 (New Position) | Filing History |
| 2024-10-18 3:31 pm Sale | 2024-09-30 | 13G | Xencor, Inc. XNCR | BlackRock Inc. BLK | 11,026,330 15.800% | -295,912 (-2.61%) | Filing History |
| 2024-10-18 12:48 pm Sale | 2024-09-30 | 13G | Xencor, Inc. XNCR | STATE STREET CORP STT | 3,119,290 4.500% | -207,566 (-6.24%) | Filing History |
| 2024-10-02 4:50 pm Unchanged | 2023-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,885,533 9.600% | 0 (Unchanged) | Filing History |
| 2024-02-16 5:43 pm Sale | 2023-12-31 | 13G | Xencor, Inc. XNCR | T. Rowe Price Investment Management, Inc. | 1,351,367 2.200% | -3,483,775 (-72.05%) | Filing History |
| 2024-02-14 6:54 pm Unchanged | 2023-12-31 | 13G | Xencor, Inc. XNCR | EcoR1 Capital, LLC | 5,282,516 8.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | Xencor, Inc. XNCR | T. Rowe Price Investment Management, Inc. | 4,835,142 2.200% | 1,100,072 (+29.45%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Xencor, Inc. XNCR | PRICE T ROWE ASSOCIATES INC | 3,489,902 5.700% | 271,141 (+8.42%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Xencor, Inc. XNCR | The Vanguard Group | 6,767,249 11.120% | 115,016 (+1.73%) | Filing History |